Top Clinical Trials companies in Spain by Current Liabilities

This ranking features the top 4 Clinical Trials companies in Spain ranked by Current Liabilities, totaling a Current Liabilities of USD 634.11 M, for February 07, 2025.

Spain

Clinical Trials
Current Liabilities
#
Name
Current Liabilities
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
ALM.MC

Almirall, S.A.

1

ALM.MC
USD 387.50 M
Dec. 31, 2023 USD 9.63 -2.28%

Spain
2
ROVI.MC

Laboratorios Farmaceuticos Rovi, S.A.

2

ROVI.MC
USD 220.58 M
Dec. 31, 2023 USD 68.35 0.94%

Spain
3
ORY.MC

Oryzon Genomics S.A.

3

ORY.MC
USD 18.12 M
Dec. 31, 2023 USD 1.52 0.94%

Spain
4
PANG.MC

Pangaea Oncology, S.A.

4

PANG.MC
USD 7.92 M
Dec. 31, 2023 USD 1.81 -0.12%

Spain
Frequently Asked Questions
  • Which Clinical Trials company in Spain has the highest Current Liabilities ?

    The Clinical Trials company in Spain with the highest Current Liabilities is Almirall, S.A. (MCE: ALM.MC) at USD 387.50 M.

  • Which Clinical Trials company in Spain has the lowest Current Liabilities ?

    The Clinical Trials company in Spain with the lowest Current Liabilities is Pangaea Oncology, S.A. (MCE: PANG.MC) at USD 7.92 M.

SV Wall Street